{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:53:06Z","timestamp":1761630786555,"version":"3.40.5"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T00:00:00Z","timestamp":1489104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ijid.2017.03.011","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T04:45:54Z","timestamp":1493354754000},"page":"98-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["From individual to herd protection with pneumococcal vaccines: the contribution of the Cuban pneumococcal conjugate vaccine implementation strategy"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0125-6361","authenticated-orcid":false,"given":"Nivaldo","family":"Linares-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda E.","family":"Toledo-Roman\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darielys","family":"Santana-Mederos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana\u00ed","family":"Garc\u00eda-Fari\u00f1as","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2099-1791","authenticated-orcid":false,"given":"Dagmar","family":"Garc\u00eda-Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0638-3896","authenticated-orcid":false,"given":"Yury","family":"Vald\u00e9s-Balb\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"V\u00e9rez-Bencomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijid.2017.03.011_bib0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jama.1993.03500020055031","article-title":"Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era","volume":"269","author":"Adams","year":"1993","journal-title":"Jama"},{"year":"2010","series-title":"Evaluaci\u00f3n econ\u00f3mica de un programa de vacunaci\u00f3n frente al neumococo en poblaci\u00f3n pedi\u00e1trica. Santiago de Compostela: Conseller\u00eda de Sanidade, Axencia de Avaliaci\u00f3n de Tecnolox\u00edas Sanitarias de Galicia, avalia-t","author":"Atienza Merino","key":"10.1016\/j.ijid.2017.03.011_bib0010"},{"key":"10.1016\/j.ijid.2017.03.011_bib0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/18.Supplement_A.35","article-title":"Some aspects of the pneumococcal carrier state","volume":"18","author":"Austrian","year":"1986","journal-title":"The Journal of antimicrobial chemotherapy"},{"year":"2011","series-title":"Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood. Health Technology Assessment (HTA)","author":"Beutels","key":"10.1016\/j.ijid.2017.03.011_bib0020"},{"issue":"3","key":"10.1016\/j.ijid.2017.03.011_bib0025","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"The Lancet infectious diseases"},{"year":"2011","series-title":"Evaluaci\u00f3n econ\u00f3mica de las vacunas hepta-, deca- y trece-valente para la prevenci\u00f3n de neumon\u00eda asociada al Streptococcus pneumoniae en ni\u00f1os menores de 5 a\u00f1os en el Per\u00fa","author":"Bola\u00f1os D\u00edaz","key":"10.1016\/j.ijid.2017.03.011_bib0030"},{"issue":"8","key":"10.1016\/j.ijid.2017.03.011_bib0035","doi-asserted-by":"crossref","first-page":"e0135270","DOI":"10.1371\/journal.pone.0135270","article-title":"Impact of Pneumococcal Conjugate Vaccine Administration in Pediatric Older Age Groups in Low and Middle Income Countries: A Systematic Review","volume":"10","author":"Bonner","year":"2015","journal-title":"PloS one"},{"issue":"5","key":"10.1016\/j.ijid.2017.03.011_bib0040","first-page":"321","article-title":"Controversial funding mechanism to fight pneumonia New financing methods show promise in fight against pneumonia, the biggest killer of children","volume":"86","author":"Braine","year":"2008","journal-title":"Bulletin of the World Health Organization"},{"issue":"10","key":"10.1016\/j.ijid.2017.03.011_bib0045","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s12325-014-0157-1","article-title":"Recommendations for Pneumococcal Immunization Outside Routine Childhood Immunization Programs in Western Europe","volume":"31","author":"Castiglia","year":"2014","journal-title":"Adv Ther"},{"key":"10.1016\/j.ijid.2017.03.011_bib0050","doi-asserted-by":"crossref","first-page":"C19","DOI":"10.1016\/j.vaccine.2013.05.045","article-title":"TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination","volume":"31","author":"Clark","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ijid.2017.03.011_bib0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1590\/S1020-49892008000800004","article-title":"Economic impact of pneumococcal conjugate vaccination in Brazil, Chile, and Uruguay","volume":"24","author":"Constenla","year":"2008","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.ijid.2017.03.011_bib0060","article-title":"Pneumococcal meningitis in Cuban children and adolescents: A fifteen years follow up","volume":"2015","author":"Dickinson Meneses Felix","year":"2015","journal-title":"Pediatrics Research International Journal"},{"issue":"41","key":"10.1016\/j.ijid.2017.03.011_bib0065","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1016\/j.vaccine.2014.06.094","article-title":"Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: A randomized phase I clinical trial","volume":"32","author":"Dotres","year":"2014","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.ijid.2017.03.011_bib0070","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1097\/INF.0000000000000083","article-title":"Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage","volume":"33","author":"Fleming-Dutra","year":"2014","journal-title":"The Pediatric infectious disease journal"},{"issue":"2","key":"10.1016\/j.ijid.2017.03.011_bib0075","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1590\/S1020-49892010000800004","article-title":"Costo-efectividad de la vacunaci\u00f3n universal antineumoc\u00f3cica en Uruguay","volume":"28","author":"Giachetto Larraz","year":"2010","journal-title":"Rev Panam Salud Publica"},{"issue":"4","key":"10.1016\/j.ijid.2017.03.011_bib0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.37757\/MR2015.V17.N4.7","article-title":"Safety and immunogenicity of Cuban antipneumococcal conjugate vaccine PCV7-TT in healthy adults","volume":"17","author":"Gonz\u00e1lez","year":"2015","journal-title":"MEDICC Review"},{"issue":"6","key":"10.1016\/j.ijid.2017.03.011_bib0085","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/infdis\/142.6.923","article-title":"Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life","volume":"142","author":"Gray","year":"1980","journal-title":"Journal of Infectious Diseases"},{"issue":"14","key":"10.1016\/j.ijid.2017.03.011_bib0090","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.vaccine.2010.01.017","article-title":"Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme","volume":"28","author":"Harboe","year":"2010","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.ijid.2017.03.011_bib0095","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ijid.2017.03.011_bib0100","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ijid.2009.05.010","article-title":"Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines","volume":"14","author":"Isaacman","year":"2010","journal-title":"International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases"},{"key":"10.1016\/j.ijid.2017.03.011_bib0105","doi-asserted-by":"crossref","first-page":"A21","DOI":"10.1016\/j.vaccine.2014.12.080","article-title":"ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions","volume":"33","author":"Jauregui","year":"2015","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.ijid.2017.03.011_bib0110","doi-asserted-by":"crossref","first-page":"e100034","DOI":"10.1371\/journal.pmed.1000348","article-title":"Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project","volume":"7","author":"Johnson","year":"2010","journal-title":"PLoS medicine"},{"issue":"13","key":"10.1016\/j.ijid.2017.03.011_bib0115","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1016\/j.vaccine.2013.03.047","article-title":"Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context?","volume":"31","author":"Kulpeng","year":"2013","journal-title":"Vaccine"},{"issue":"9568","key":"10.1016\/j.ijid.2017.03.011_bib0120","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0140-6736(07)60539-X","article-title":"Pneumococcal vaccination and public health","volume":"369","author":"Levine","year":"2007","journal-title":"Lancet"},{"issue":"sup","key":"10.1016\/j.ijid.2017.03.011_bib0125","first-page":"71","article-title":"La nueva vacuna cubana antineumoc\u00f3cica, de las evidencias cient\u00edficas disponibles, a la estrategia de evaluaci\u00f3n cl\u00ednica y de impacto","volume":"89","author":"Linares-P\u00e9rez","year":"2017","journal-title":"Rev Cub Ped"},{"key":"10.1016\/j.ijid.2017.03.011_bib0130","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1097\/INF.0000000000000084","article-title":"Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization","volume":"33","author":"Loo","year":"2014","journal-title":"The Pediatric infectious disease journal"},{"issue":"Suppl 2","key":"10.1016\/j.ijid.2017.03.011_bib0135","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1097\/INF.0000000000000082","article-title":"Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia","volume":"33","author":"Loo","year":"2014","journal-title":"The Pediatric infectious disease journal"},{"issue":"5","key":"10.1016\/j.ijid.2017.03.011_bib0140","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.ijid.2017.03.011_bib0145","doi-asserted-by":"crossref","first-page":"A154","DOI":"10.1016\/j.vaccine.2014.12.039","article-title":"Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru","volume":"33S","author":"Mezones-Holguin","year":"2015","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.ijid.2017.03.011_bib0150","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"The Lancet Infectious diseases"},{"key":"10.1016\/j.ijid.2017.03.011_bib0155","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1097\/INF.0000000000001288","article-title":"Cost-effectiveness and Health Benefits of Pediatric 23-valent Pneumococcal Polysaccharide Vaccine, 7-valent Pneumococcal Conjugate Vaccine and Forecasting 13-valent Pneumococcal Conjugate Vaccine in China","volume":"35","author":"Mo","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijid.2017.03.011_bib0160","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jval.2011.05.025","article-title":"Evaluaci\u00f3n Econ\u00f3mica de un Programa de Inmunizaci\u00f3n Infantil en M\u00e9xico Basado en la Vacuna Neumoc\u00f3cica Conjugada 13-Valente","volume":"14","author":"Muci\u00f1o-Ortega","year":"2011","journal-title":"Value in Health"},{"issue":"4","key":"10.1016\/j.ijid.2017.03.011_bib0165","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.inhe.2011.08.004","article-title":"Cost effectiveness of child pneumococcal conjugate vaccination in middle-income countries","volume":"3","author":"Nakamura","year":"2011","journal-title":"Int Health"},{"issue":"51","key":"10.1016\/j.ijid.2017.03.011_bib0170","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1016\/j.vaccine.2015.10.022","article-title":"A cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda","volume":"33","author":"Ngabo","year":"2015","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.ijid.2017.03.011_bib0175","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0264-410X(02)00807-1","article-title":"The potential indirect effect of conjugate pneumococcal vaccines","volume":"21","author":"O\u2019Brien","year":"2003","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ijid.2017.03.011_bib0180","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/521833","article-title":"Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial","volume":"196","author":"O'Brien","year":"2007","journal-title":"Journal of Infectious Diseases"},{"issue":"8","key":"10.1016\/j.ijid.2017.03.011_bib0185","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/521833","article-title":"Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial","volume":"196","author":"O'Brien","year":"2007","journal-title":"The Journal of infectious diseases"},{"issue":"1","key":"10.1016\/j.ijid.2017.03.011_bib0190","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12962-015-0032-1","article-title":"Cost-effectiveness analysis of the available pneumococcal conjugated vaccines for children under five years in Colombia","volume":"13","author":"Ord\u00f3\u00f1ez","year":"2015","journal-title":"Cost Effectiveness and Resource Allocation"},{"issue":"6","key":"10.1016\/j.ijid.2017.03.011_bib0195","doi-asserted-by":"crossref","first-page":"e1103","DOI":"10.1542\/peds.2008-3422","article-title":"Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis","volume":"123","author":"Pavia","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijid.2017.03.011_bib0200","doi-asserted-by":"crossref","first-page":"A143","DOI":"10.1016\/j.vaccine.2014.12.078","article-title":"Cost-effectiveness analysis of pneumococcal conjugate vaccine introduction in Paraguay","volume":"33S","author":"Pe\u00f1a Kieninger","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ijid.2017.03.011_bib0205","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1128\/JCM.01917-12","article-title":"Changes in molecular epidemiology of Streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales","volume":"51","author":"Pichon","year":"2013","journal-title":"Journal of clinical microbiology"},{"issue":"1","key":"10.1016\/j.ijid.2017.03.011_bib0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"The Journal of infectious diseases"},{"issue":"2","key":"10.1016\/j.ijid.2017.03.011_bib0215","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0749-3797(03)00120-X","article-title":"Standards for adult immunization practices","volume":"25","author":"Poland","year":"2003","journal-title":"American journal of preventive medicine"},{"issue":"30","key":"10.1016\/j.ijid.2017.03.011_bib0220","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1016\/j.vaccine.2010.04.042","article-title":"Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA","volume":"28","author":"Regev-Yochay","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.ijid.2017.03.011_bib0225","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s40273-016-0439-3","article-title":"Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review","volume":"34","author":"Saokaew","year":"2016","journal-title":"PharmacoEconomics"},{"issue":"1","key":"10.1016\/j.ijid.2017.03.011_bib0230","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.provac.2009.07.032","article-title":"Pneumococcal conjugate vaccines: what do we know and what do we need?","volume":"1","author":"Schranz","year":"2009","journal-title":"Procedia in Vaccinology"},{"issue":"7","key":"10.1016\/j.ijid.2017.03.011_bib0235","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert review of vaccines"},{"issue":"11","key":"10.1016\/j.ijid.2017.03.011_bib0240","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jama.1995.03520350041026","article-title":"Risk factors for primary invasive pneumococcal disease among children in Finland","volume":"273","author":"Takala","year":"1995","journal-title":"Jama"},{"issue":"January (1)","key":"10.1016\/j.ijid.2017.03.011_bib0245","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1097\/INF.0000000000001341","article-title":"Prevalence of Pneumococcal Nasopharyngeal Carriage Among Children 2-18 Months of Age: Baseline Study Pre Introduction of Pneumococcal Vaccination in Cuba","volume":"36","author":"Toledo","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"sup","key":"10.1016\/j.ijid.2017.03.011_bib0250","first-page":"51","article-title":"Colonizaci\u00f3n nasofar\u00edngea por neumococos en la poblaci\u00f3n infantil cubana, evidencias basadas en estudios de prevalencia","volume":"89","author":"Toledo","year":"2017","journal-title":"Rev Cub Ped"},{"issue":"3","key":"10.1016\/j.ijid.2017.03.011_bib0255","first-page":"117","article-title":"Serotipos y resistencia antimicrobiana de aislamientos men\u00edngeos de Streptococcus pneumoniae. Cuba, 2007-2012","volume":"23","author":"Tora\u00f1o","year":"2014","journal-title":"VacciMonitor"},{"issue":"sup","key":"10.1016\/j.ijid.2017.03.011_bib0260","first-page":"31","article-title":"Serotipos de Streptococcus pneumoniae responsables de enfermedad invasiva en ni\u00f1os cubanos","volume":"89","author":"Tora\u00f1o-Peraza","year":"2017","journal-title":"Rev Cub Ped"},{"issue":"1","key":"10.1016\/j.ijid.2017.03.011_bib0265","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1574-6976.2006.00053.x","article-title":"Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines","volume":"31","author":"Trotter","year":"2007","journal-title":"FEMS microbiology reviews"},{"key":"10.1016\/j.ijid.2017.03.011_bib0270","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1016\/j.vaccine.2011.04.111","article-title":"Cost-effectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina","volume":"29","author":"Urue\u00f1a","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2017.03.011_bib0275","first-page":"czs012","article-title":"An analysis of GAVI, the Global Fund and World Bank support for human resources for health in developing countries","volume":"2012","author":"Vujicic","year":"2016","journal-title":"Health policy and planning"},{"issue":"32","key":"10.1016\/j.ijid.2017.03.011_bib0280","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1016\/j.vaccine.2012.04.093","article-title":"Pneumococcal vaccines WHO position paper \u20132012\u2013recommendations","volume":"30","author":"WHO","year":"2012","journal-title":"Vaccine"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971217300942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971217300942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T12:40:20Z","timestamp":1601988020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971217300942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":56,"alternative-id":["S1201971217300942"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2017.03.011","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From individual to herd protection with pneumococcal vaccines: the contribution of the Cuban pneumococcal conjugate vaccine implementation strategy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2017.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}